Ai er Eye buys two stakes to enter Beijing market

Our News ai er Ophthalmology (300015) in Beijing continue to implement mergers and acquisitions pull growth strategy. Company announced recently, to the super raise funds in the acquisition of 91.9442 million yuan in Beijing, British-wisdom Eye Hospital 71.41% Equity, to super raise funds in the acquisition of 1.25 million Yuan Beijing Huaxin glasses company 100% Equity.　　According to the eye, the company has achieved a distribution of outlets in the Beijing area. Bulletin shows that Beijing British wisdom is one of the few Beijing can carry out the whole eye operation of large-scale professional eye hospital, its hospital size, surgery volume and technical strength of the forefront of Beijing eye industry, especially in the vitrectomy and retinal detachment and other complex ocular fundus diseases have national influence, patients from all over the country, With good social visibility and reputation. The audit report shows that 2009 Beijing British-Wisdom to achieve operating income of 50.6359 million yuan, net profit of 11.2456 million Yuan; 2010 1-June, Beijing, Britain and wisdom to achieve business income of 26.6938 million yuan, net profit of 6.9366 million yuan.　　As at June 30, 2010, the company's total assets of 30.0182 million yuan, net assets of 14.2267 million yuan. For the reason for the higher premium acquisition of Beijing, Ai Er, said that Beijing English-Chinese medical Insurance Sentinel three-level ophthalmic hospital, the International Emergency Relief Organization (SOS) Sentinel Eye Hospital, 48 foreign embassies designated ophthalmic hospital, the world's 31 international insurance companies contracted eye Hospital, Beijing is one of the most accepted international patients, therefore, the acquisition of the target has a certain scarcity of resources.　　Ai ER is optimistic about the long-term strategic value of the ophthalmic resources possessed by the Beijing Institute of English and Wisdom. At the same time, AI Seoul to raise funds to exceed 1.25 million yuan acquisition of Beijing Huaxin 100% Equity.　　The acquisition of the Department of Ophthalmology in Beijing, the Medical Optometry mirror Service project to achieve, and further improve the eye in the Beijing market, sales revenue and market share. Love Ophthalmology believes that through the above two transactions, the company achieved in the Beijing area network layout, thereby helping to expand the company's market coverage area, effectively improve market share and sales revenue, enhance the company's sustainable development capacity and core competitiveness.